| Healthcare and Medical Technology |
1 |
1 |
| Lung Cancer |
0 |
0.97 |
| Cancer |
0 |
0.99 |
| Biologic Therapy |
0 |
0.9 |
| Genomic Medicine |
0 |
0.77 |
| Liquid Biopsy |
0 |
0.72 |
| Colorectal Cancer |
0 |
0.71 |
| Pancreatic Cancer |
0 |
0.71 |
| Colon Cancer |
0 |
0.7 |
| Lung Metastases |
0 |
0.59 |
| Toxicology |
0 |
0.59 |
| Precision Medicine |
0 |
0.14 |
| Clinical Research |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Medical Innovations |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |
| Biomedical Technology |
0 |
0.04 |
| KRAS |
0 |
0.04 |
| Microsatellite Instability |
0 |
0.04 |
| Biopsy |
0 |
0.02 |
| Cardiovascular disease |
0 |
0.02 |
| Cardiovascular Risk Management |
0 |
0.02 |
| Child |
0 |
0.02 |
| Diversity |
0 |
0.02 |
| Face |
0 |
0.02 |
| Genetics |
0 |
0.02 |
| Gout |
0 |
0.02 |
| Hospital |
0 |
0.02 |
| Immunomodulator |
0 |
0.02 |
| Lung |
0 |
0.02 |
| Medical Oncology |
0 |
0.02 |
| Methylation |
0 |
0.02 |
| Mobile Health |
0 |
0.02 |
| Pollutant |
0 |
0.02 |
| Sexual Behavior |
0 |
0.02 |
| Social Determinants of Health |
0 |
0.02 |
| Surgery |
0 |
0.02 |
| Tobacco Cessation |
0 |
0.02 |
| Tobacco Use |
0 |
0.02 |
| Translational Research |
0 |
0.02 |
| Tumor |
0 |
0.02 |